← All organizations
First clinical trial
Feb 1, 2014Last known activity
Jun 30, 2019
Acquired by Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical → Brickell Biotech, Inc. → Vical on Jun 3, 2019
Timeline
Drugs by trial phase (23 distinct, 31 trials)
Phase 3 (0 own, 5 via acquisition)
Phase 2 (0 own, 9 via acquisition)
Indications
Subsidiaries (1 direct, 25 total across the full acquisition tree)
- Vical
- Brickell Biotech, Inc. L2
- Vical L3
- Brickell Biotech, Inc. L4
- Vical L5
- Brickell Biotech, Inc. L6
- Vical L7
- Brickell Biotech, Inc. L8
- Vical L9
- Brickell Biotech, Inc. L10
- Vical L11
- Brickell Biotech, Inc. L12
- Vical L13
- Brickell Biotech, Inc. L14
- Vical L15
- Brickell Biotech, Inc. L16
- Vical L17
- Brickell Biotech, Inc. L18
- Vical L19
- Brickell Biotech, Inc. L20
- Vical L21
- Brickell Biotech, Inc. L22
- Vical L23
- Brickell Biotech, Inc. L24
- Vical L25
Recent trials (17)
- NCT03836287Lead sponsorPhase 3Jun 30, 2019
- NCT03948646Lead sponsorPhase 3Jun 30, 2019
- NCT03785587Study directorPhase 2Dec 21, 2018
- NCT03785587Lead sponsorPhase 2Dec 21, 2018
- NCT03627468Lead sponsorPhase 3Aug 20, 2018
- NCT03627468Study directorPhase 3Aug 20, 2018
- NCT03089775Lead sponsorPhase 1Mar 14, 2017
- NCT03089775Study directorPhase 1Mar 14, 2017
- NCT03024255Study directorPhase 2Dec 1, 2016
- NCT03024255Lead sponsorPhase 2Dec 1, 2016
- NCT02682238Lead sponsorPhase 2Feb 1, 2016
- NCT02590289Lead sponsorPhase 1Oct 1, 2015
- NCT02590289Study directorPhase 1Oct 1, 2015
- NCT02336503Study directorPhase 2Feb 1, 2015
- NCT02336503Lead sponsorPhase 2Feb 1, 2015
Details
- Founded
- Miami, FL, US Jun 1, 2009
- Last known activity
- Jun 30, 2019